- KYPROLIS® (carfilzomib) is indicated in combination with dexamethasone, or with lenalidomide plus dexamethasone, or with daratumumab plus dexamethasone, ... Read More Read Less
There is a KYPROLIS® (carfilzomib) combination for many of your appropriate patients at first relapse
Carfilzomib (KYPROLIS®) is part of the International Myeloma Working Group (IMWG) and National Comprehensive Cancer Network® (NCCN®) preferred treatment recommendations.1,2